通读环状RNA RCRIN抑制代谢功能障碍相关脂肪性肝病
研究通过外显子捕获RNA测序在3例MASLD患者和3例无MASLD对照肝组织中鉴定通读环状RNA,发现RCRIN在正常肝高表达、在MASLD肝中下调;肝细胞Rcrin缺失导致脂质蓄积和MASLD发生,过表达则抑制MASLD进展,机制涉及RCRIN结合RPL8并招募RNF2促其降解;合成RCRIN和GalNAc-Rpl8小干扰RNA均抑制小鼠已建立MASLD的发病。
要点
- 在3例MASLD和3例对照肝组织中鉴定出1,126个通读环状RNA。
- RCRIN在正常肝高表达、在MASLD肝中下调,肝细胞Rcrin缺失导致脂质蓄积和MASLD发生。
- RCRIN过表达和RPL8敲低均抑制小鼠MASLD发生与进展。
核心结论
- RCRIN在体内发挥功能,对MASLD发病具有抑制作用,RCRIN和RPL8可能成为候选核酸药物治疗MASLD的靶点。
研究设计与样本
- 采用外显子捕获RNA测序分析3例MASLD患者和3例无MASLD对照的肝组织。
- 利用肝细胞特异性Rcrin缺失或过表达研究MASLD发病机制,并合成RCRIN和GalNAc-Rpl8小干扰RNA在已建立MASLD的小鼠中验证。
主要发现
- 在MASLD患者肝组织中鉴定出1,126个通读环状RNA。
- RCRIN在正常肝高表达、在MASLD肝中下调。
- 肝细胞Rcrin缺失导致脂质蓄积和MASLD发生,Rcrin过表达抑制MASLD进展。
- 正常肝细胞中高表达RCRIN结合RPL8蛋白并招募RNF2促其降解,减少含RPL8核糖体数量和脂质蓄积。
- MASLD肝中RCRIN低表达导致RPL8释放,增加含RPL8核糖体数量和脂质合成,导致更重脂质蓄积和内质网应激。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The molecular mechanisms underlying metabolic dysfunction-associated steatotic liver disease (MASLD) remain elusive and whether non-coding RNAs can serve as biomarkers and therapeutic targets in MASLD has not been determined. METHODS: Exon capture RNA-sequencing analysis was used to identify read-through circular RNAs (rt-circRNAs) in livers from three patients with MASLD and three controls without MASLD. Hepatocyte-specific deletion or overexpression of rt-circRNA RCRIN were utilized to study MASLD pathogenesis. RESULTS: We identified 1,126 rt-circRNAs in liver tissues from patients with MASLD. RCRIN was highly expressed in normal livers and was downregulated in MASLD livers. Rcrin deletion in hepatocytes caused lipid accumulation and MASLD development, while Rcrin overexpression suppressed MASLD progression. Mechanistically, in normal hepatocytes, highly expressed RCRIN bound to RPL8 protein to recruit RNF2 for its degradation, reducing RPL8-containing ribosome numbers and lipid accumulation. In MASLD livers, low RCRIN expression led to the release of RPL8 protein, increasing RPL8-containing ribosome numbers and lipid synthesis, and leading to greater lipid accumulation and endoplasmic reticulum stress. We synthesized RCRIN and N-acetylgalactosamine (GalNAc)-Rpl8 small-interfering RNAs, which both suppressed the pathogenesis of established MASLD in mice. CONCLUSIONS: Our findings reveal an in vivo function of the rt-circRNA RCRIN, show its inhibitory effects in MASLD pathogenesis, and indicate that RCRIN and RPL8 may be therapeutic targets for candidate nucleic acid drugs to treat MASLD. IMPACT AND IMPLICATIONS: Our finds reveal a novel mechanism connecting a read-through circular RNA RCRIN, ribosome heterogeneity and metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis. In normal hepatocytes, RCRIN exerts its role by reducing liver lipid accumulation and endoplasmic reticulum stress through promotion of RPL8 degradation. In patients with MASLD, lower RCRIN levels lead to the release of RPL8 to form RPL8-containing ribosomes, promoting lipid accumulation and endoplasmic reticulum stress. RCRIN overexpression and RPL8 depletion dramatically suppress MASLD development and progression. Our findings indicate that RCRIN and RPL8 might be potential therapeutic targets for the treatment of patients with MASLD.
引用
- Wang Y, Wang J, Zhou Z, et al. A read-through circular RNA RCRIN inhibits metabolic dysfunction-associated steatotic liver disease. J Hepatol. 2024. PMID: 39667599. doi:10.1016/j.jhep.2024.11.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。